Life Science Company News

Reset
Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

StateHouse Provides an Update on Application for Management Cease Trade Order

Read more ››
By: GlobeNewswire - 19 Apr 2024

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  ASLAN Pharmaceuticals Ltd.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Iovance Biotherapeutics, Inc.

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Celularity Inc.

Stacey Lasser of Mednet to Present at the 2nd Annual Clinical Outsourcing Group New England Conference in Boston

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024
Related companies:  MedNet Solutions

Prelude and Loyal: Collaborating to Extend Canine Lifespans

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024

AMERICAN SKIN ASSOCIATION EARNS CANDID'S 2024 PLATINUM SEAL OF TRANSPARENCY AND CHARITY NAVIGATOR'S FOUR-STAR RATING

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024

FDA Roundup: April 19, 2024

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024
Related companies:  U.S. Food and Drug Administration

Grifols 2023 Annual Report on Form 20-F filed with the SEC

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024
Related companies:  Grifols USA, LLC | Grifols Biologicals Inc. | Grifols Therapeutics, Inc.

NCPDP's National Facilitator Model Pilot Project Enters Second Phase

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024

Vayiz Unveils PTLC - Mark 1: Revolutionizing Medical Diagnostics with Pioneering AI Technology

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Alvotech

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  ProQR Therapeutics NV

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®

Read more ››
By: GlobeNewswire - 19 Apr 2024

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Ocugen, Inc.

Preliminary Results for the Year Ended 31 December 2023

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Biodexa Pharmaceuticals PLC

NeuroMetrix Announces Steps Taken to Enhance Shareholder Value

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  NeuroMetrix, Inc.

3Daughters Named “Startup of the Year” at BioLabs Philadelphia Investor Day 2024

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  3Daughters

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023

Read more ››
By: GlobeNewswire - 19 Apr 2024

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  CorMedix Inc.
Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »